Educational content on VJRegenMed is intended for healthcare professionals only. By visiting this website and accessing this information you confirm that you are a healthcare professional.

Advanced Therapies Week 2022 and Manufacturing View overview page

1:38
Overcoming manufacturing issues in gene therapies for rare diseases
John Maslowski • 27 Jan 2022
2:12
Innovations in treating rare diseases with gene therapies
John Maslowski • 27 Jan 2022
1:36
Meeting the growing demand for gene therapy manufacturing
John Maslowski • 27 Jan 2022
0:46
Allogeneic therapy highlights at Advanced Therapies Week 2022
Jeff Liter • 27 Jan 2022
3:09
The development of human acellular vessels and its advantages
Alan Kypson • 22 Mar 2022
3:16
The future of small-diameter human acellular vessels
Alan Kypson • 22 Mar 2022
3:03
Tangential Flow Depth Filtration in viral vector manufacturing
Rachel Legmann • 27 Jan 2022
1:58
Adapting to challenges in manufacturing cell therapies for solid tumors
Christopher Ballas • 27 Jan 2022
1:44
The role of automation in manufacturing CAR T-cells
Bruce Levine • 27 Jan 2022
4:51
Challenges in manufacturing viral vectors for the clinic
Nathalie Clement • 27 Jan 2022
1:25
Strategies to increase cell therapy manufacturing capabilities
Shannon Eaker • 27 Jan 2022
3:43
Digitization in the advanced therapy sector
Shannon Eaker • 27 Jan 2022
2:57
Adapting cell therapies to solid tumors
Nina Bauer • 26 Jan 2022
3:17
Overview of the ekko™ acoustic cell processing system
Nina Bauer • 26 Jan 2022
2:27
Improving the scalability of advanced therapies
Delara Motlagh • 27 Jan 2022
3:32
Addressing issues in patients accessing advanced therapies
Jason Foster • 27 Jan 2022
The content of VJRegenMed is intended for healthcare professionals